Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CervoMed (CRVO) Equity Ratio (2022 - 2025)

CervoMed's Equity Ratio history spans 9 years, with the latest figure at 0.85 for Q3 2025.

  • For Q3 2025, Equity Ratio fell 8.98% year-over-year to 0.85; the TTM value through Sep 2025 reached 0.85, down 8.98%, while the annual FY2024 figure was 0.91, 23.02% up from the prior year.
  • Equity Ratio for Q3 2025 was 0.85 at CervoMed, down from 0.88 in the prior quarter.
  • Across five years, Equity Ratio topped out at 7.79 in Q1 2024 and bottomed at 10.44 in Q2 2023.
  • The 4-year median for Equity Ratio is 0.85 (2025), against an average of 0.83.
  • The largest annual shift saw Equity Ratio tumbled 1038.41% in 2023 before it skyrocketed 191.01% in 2024.
  • A 4-year view of Equity Ratio shows it stood at 8.01 in 2022, then surged by 109.24% to 0.74 in 2023, then rose by 23.02% to 0.91 in 2024, then fell by 6.62% to 0.85 in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Equity Ratio are 0.85 (Q3 2025), 0.88 (Q2 2025), and 0.9 (Q1 2025).